Temozolomide therapy for patients with non-small cell lung cancer, breast cancer, or melanoma brain metastases

Authors :: E. A. Moskvina
Vladislav Karahan
G. E. Chmutin
Vera Gorbunova
Vladimir Aloshin
M. B. Bychkov
S. B. Alieva
N. N. Blokhin
D. R. Naskhletashvili
Zoya Michina
Source :: Journal of Clinical Oncology. 28:e12539-e12539
Publication Year :: 2010
Publisher :: American Society of Clinical Oncology (ASCO), 2010.
Abstract: e12539 Background: To assess the efficacy of temozolomide (TMZ) as monotherapy, RNMZ combined with whole brain irradiation (WBI), or combined chemotherapy of RNMZ and irinotecan (I) in patients (pt...

Subjects :: Oncology
CA15-3
Cancer Research
medicine.medical_specialty
Temozolomide
business.industry
Melanoma
Cancer
Combination chemotherapy
medicine.disease
Irinotecan
Breast cancer
Internal medicine
medicine
Lung cancer
business
medicine.drug

Full Text Access

Tools